Biomonitors of cardiac injury and performance: B-type natriuretic peptide and troponin as monitors of hemodynamics and oxygen transport balance

Pediatric Critical Care Medicine

Volumn 12, Issue 4 SUPPL., 2011, Pages

  Domico, Michelle ^a,b   Checchia, Paul A ^c  

^a CHILDREN S HOSPITAL OF ORANGE COUNTY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

B type natriuretic peptide; biomarkers; cardiac disease; hemodynamics; troponin

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; CREATINE KINASE; TROPONIN I; TROPONIN T;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ACUTE KIDNEY FAILURE; ADULT RESPIRATORY DISTRESS SYNDROME; BIOLOGICAL MONITORING; CARDIAC PATIENT; CAVOPULMONARY CONNECTION; COCHRANE LIBRARY; CONFERENCE PAPER; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CREATINE KINASE BLOOD LEVEL; DIAGNOSTIC ACCURACY; DIURESIS; DRUG HALF LIFE; EXTUBATION; HALF LIFE TIME; HEART FAILURE; HEART INJURY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HEART SINGLE VENTRICLE; HEMODIALYSIS; HEMODYNAMIC MONITORING; HUMAN; INTENSIVE CARE; KIDNEY FAILURE; LUNG ARTERY PRESSURE; LUNG BLOOD FLOW; LUNG CIRCULATION; LUNG EMBOLISM; LUNG VASCULAR RESISTANCE; MEDLINE; NATRIURESIS; OXYGEN TRANSPORT; PERIOPERATIVE PERIOD; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PULMONARY HYPERTENSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SENSITIVITY AND SPECIFICITY; SEPSIS; SEPTIC SHOCK; SYSTEMATIC REVIEW; SYSTEMIC CIRCULATION; SYSTOLIC DYSFUNCTION; VASODILATATION;

EID: 79959970076     PISSN: 15297535     EISSN: 19473893     Source Type: Journal    
DOI: 10.1097/PCC.0b013e318221178d     Document Type: Conference Paper

References (148)

1. Sudoh T, Kangawa K, Minamino N, et al: A new natriuretic peptide in porcine brain. Nature 1988; 332:78-81. (Pubitemid 18083551)
2. Levin ER, Gardner DG, Samson WK: Natriuretic peptides. N Engl J Med 1998; 339: 321-328. (Pubitemid 28366422)
3. Costello JM, Goodman DM, Green TP: A review of the natriuretic hormone system's diagnostic and therapeutic potential in critically ill children. Pediatr Crit Care Med 2006; 7:308-318. (Pubitemid 44048272)
4. Suga S, Nakao K, Hosoda K, et al: Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinology 1992; 130:229-239.
5. Godkar D, Bachu K, Dave B, et al: B-type natriuretic peptide (BNP) and proBNP: Role of emerging markers to guide therapy and determine prognosis in cardiovascular disorders. Am J Ther 2008; 15:150-156. (Pubitemid 351450779)
6. Mü nzel T, Feil R, Mü lsch A, et al: Physiology and pathophysiology of vascular sig- naling controlled by guanosine 3,5- cyclic monophosphate-dependent protein kinase [corrected]. Circulation 2003; 108: 2172-2183.
7. Magga J, Puhakka M, Hietakorpi S, et al: Atrial natriuretic peptide, B-type natriuretic peptide, and serum collagen markers after acute myocardial infarction. J Appl Physiol 2004; 96:1306-1311. (Pubitemid 38392665)
8. Hall C: Essential biochemistry and physiology of (NT-pro)BNP. Eur J Heart Fail 2004; 6:257-260. (Pubitemid 38253043)
9. Wiley CL, Switzer SP, Berg RL, et al: Association of B-type natriuretic Peptide levels with estimated glomerular filtration rate and congestive heart failure. Clin Med Res 2010; 8:7-12.
10. Rodseth RN: B type natriuretic peptide-a diagnostic breakthrough in peri-operative cardiac risk assessment? Anaesthesia 2009; 64:165-178.
11. Mir TS, Flato M, Falkenberg J, et al: Plasma concentrations of N-terminal brain natriuretic peptide in healthy children, adolescents, and young adults: Effect of age and gender. Pediatr Cardiol 2006; 27:73-77.
12. Maisel A: Algorithms for using B-type natriuretic peptide levels in the diagnosis and management of congestive heart failure. Crit Pathw Cardiol 2002; 1:67-73.
13. Casserly B, Klinger JR: Brain natriuretic peptide in pulmonary arterial hypertension: Biomarker and potential therapeutic agent. Drug Des Devel Ther 2009; 3:269-287.
14. Cavallazzi R, Nair A, Vasu T, et al: Natriuretic peptides in acute pulmonary embolism: A systematic review. Intensive Care Med 2008; 34:2147-2156.
15. Post F, Weilemann LS, Messow CM, et al: B-type natriuretic peptide as a marker for sepsis-induced myocardial depression in intensive care patients. Crit Care Med 2008; 36:3030-3037.
16. Kandil E, Burack J, Sawas A, et al: B-type natriuretic peptide: A biomarker for the diagnosis and risk stratification of patients with septic shock. Arch Surg 2008; 143: 242-246. (Pubitemid 351439272)
17. Reel B, Oishi PE, Hsu JH, et al: Early elevations in B-type natriuretic peptide levels are associated with poor clinical outcomes in pediatric acute lung injury. Pediatr Pulmonol 2009; 44:1118-1124.
18. Domico M, Liao P, Anas N, et al: Elevation of brain natriuretic peptide levels in children with septic shock. Pediatr Crit Care Med 2008; 9:478-483.
19. Austin WJ, Bhalla V, Hernandez-Arce I, et al: Correlation and prognostic utility of Btype natriuretic peptide and its aminoterminal fragment in patients with chronic kidney disease. Am J Clin Pathol 2006; 126: 506-512. (Pubitemid 44498499)
20. Kawamura T, Wago M, Kawaguchi H, et al: Plasma brain natriuretic peptide concentrations in patients with Kawasaki disease. Pediatr Int 2000; 42:241-248. (Pubitemid 30409336)
21. Hayakawa H, Komada Y, Hirayama M, et al: Plasma levels of natriuretic peptides in relation to doxorubicin-induced cardiotoxicity and cardiac function in children with cancer. Med Pediatr Oncol 2001; 37:4-9. (Pubitemid 32613628)
22. Maher KO, Reed H, Cuadrado A, et al: Btype natriuretic peptide in the emergency diagnosis of critical heart disease in children. Pediatrics 2008; 121:e1484-e1488.
23. Law YM, Hoyer AW, Reller MD, et al: Accuracy of plasma B-type natriuretic peptide to diagnose significant cardiovascular disease in children: The Better Not Pout Children! Study. J Am Coll Cardiol 2009; 54: 1467-1475.
24. Koulouri S, Acherman RJ, Wong PC, et al: Utility of B-type natriuretic peptide in differentiating congestive heart failure from lung disease in pediatric patients with respiratory distress. Pediatr Cardiol 2004; 25: 341-346. (Pubitemid 38989517)
25. Westerlind A, Wåhlander H, Berggren H, et al: Plasma levels of natriuretic peptide type B and A in children with heart disease with different types of cardiac load or systolic dysfunction. Clin Physiol Funct Imaging 2008; 28:277-284. (Pubitemid 351858811)
26. Yoshimura M, Yasue H, Okumura K, et al: Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation 1993; 87:464-469. (Pubitemid 23040916)
27. Krishnaswamy P, Lubien E, Clopton P, et al: Utility of B-natriuretic peptide levels in identifying patients with left ventricular systolic or diastolic dysfunction. Am J Med 2001; 111:274-279. (Pubitemid 32885622)
28. Lukowicz TV, Fischer M, Hense HW, et al: BNP as a marker of diastolic dysfunction in the general population: Importance of left ventricular hypertrophy. Eur J Heart Fail 2005; 7:525-531. (Pubitemid 40732982)
29. Grewal J, McKelvie R, Lonn E, et al: BNP and NT-proBNP predict echocardiographic severity of diastolic dysfunction. Eur J Heart Fail 2008; 10:252-259. (Pubitemid 351343862)
30. Eerola A, Jokinen E, Pihkala JI: Serum levels of natriuretic peptides in children with various types of loading conditions. Scand Cardiovasc J 2009; 43:187-193.
31. Kunii Y, Kamada M, Ohtsuki S, et al: Plasma brain natriuretic peptide and the evaluation of volume overload in infants and children with congenital heart disease. Acta Med Okayama 2003; 57:191-197. (Pubitemid 37386876)
32. Suda K, Matsumura M, Matsumoto M: Clinical implication of plasma natriuretic peptides in children with ventricular septal defect. Pediatr Int 2003; 45:249-254. (Pubitemid 36995093)
33. Lechner E, Schreier-Lechner EM, Hofer A, et al: Aminoterminal brain-type natriuretic peptide levels correlate with heart failure in patients with bidirectional Glenn anastomosis and with morbidity after the Fontan operation. J Thorac Cardiovasc Surg 2009; 138:560-564.
34. Sun LS, Dominguez C, Mallavaram NA, et al: Dysfunction of atrial and B-type natriuretic peptides in congenital univentricular defects. J Thorac Cardiovasc Surg 2005; 129:1104-1110. (Pubitemid 40631433)
35. Nozohoor S, Nilsson J, Lü hrs C, et al: Btype natriuretic peptide as a predictor of postoperative heart failure after aortic valve replacement. J Cardiothorac Vasc Anesth 2009; 23:161-165.
36. Law YM, Ettedgui J, Beerman L, et al: Comparison of plasma B-type natriuretic peptide levels in single ventricle patients with systemic ventricle heart failure versus isolated cavopulmonary failure. Am J Cardiol 2006; 98:520-524. (Pubitemid 44162880)
37. Koch A, Zink S, Singer H: B-type natriuretic peptide in paediatric patients with congenital heart disease. Eur Heart J 2006; 27:861-866.
38. Koch AM, Rauh M, Zink S, et al: Decreasing ratio of plasma N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide according to age. Acta Paediatr 2006; 95:805-809. (Pubitemid 44261738)
39. Mir TS, Marohn S, Läer S, et al: Plasma concentrations of N-terminal pro-brain natriuretic peptide in control children from the neonatal to adolescent period and in children with congestive heart failure. Pediatrics 2002; 110:e76.
40. Price JF, Thomas AK, Grenier M, et al: Btype natriuretic peptide predicts adverse cardiovascular events in pediatric outpatients with chronic left ventricular systolic dysfunction. Circulation 2006; 114: 1063-1069. (Pubitemid 44358883)
41. Mangat J, Carter C, Riley G, et al: The clinical utility of brain natriuretic peptide in paediatric left ventricular failure. Eur J Heart Fail 2009; 11:48-52.
42. Cowley CG, Bradley JD, Shaddy RE: B-type natriuretic peptide levels in congenital heart disease. Pediatr Cardiol 2004; 25: 336-340. (Pubitemid 38989516)
43. Karthikeyan G, Moncur RA, Levine O, et al: Is a pre-operative brain natriuretic peptide or N-terminal pro-B-type natriuretic peptide measurement an independent predictor of adverse cardiovascular outcomes within 30 days of noncardiac surgery? A systematic review and meta-analysis of observational studies. J Am Coll Cardiol 2009; 54: 1599-1606.
44. Ryding AD, Kumar S, Worthington AM, et al: Prognostic value of brain natriuretic peptide in noncardiac surgery: A metaanalysis. Anesthesiology 2009; 111:311-319.
45. Rodseth RN, Padayachee L, Biccard BM: A meta-analysis of the utility of pre-operative brain natriuretic peptide in predicting early and intermediate-term mortality and major adverse cardiac events in vascular surgical patients. Anaesthesia 2008; 63:1226-1233.
46. Fox AA, Muehlschlegel JD, Body SC, et al: Comparison of the utility of preoperative versus postoperative B-type natriuretic peptide for predicting hospital length of stay and mortality after primary coronary artery bypass grafting. Anesthesiology 2010; 112: 842-851.
47. Cuthbertson BH, McKeown A, Croal BL, et al: Utility of B-type natriuretic peptide in predicting the level of peri- and postoperative cardiovascular support required after coronary artery bypass grafting. Crit Care Med 2005; 33:437-442. (Pubitemid 40216560)
48. de Lemos JA, Morrow DA, Bentley JH, et al: The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001; 345:1014-1021.
49. Jarai R, Fellner B, Haoula D, et al: Early assessment of outcome in cardiogenic shock: Relevance of plasma N-terminal pro- B-type natriuretic peptide and interleukin-6 levels. Crit Care Med 2009; 37:1837-1844.
50. Almog Y, Novack V, Megralishvili R, et al: Plasma level of N terminal pro-brain natriuretic peptide as a prognostic marker in critically ill patients. Anesth Analg 2006; 102:1809-1815. (Pubitemid 43799860)
51. Logeart D, Thabut G, Jourdain P, et al: Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. J Am Coll Cardiol 2004; 43:635-641. (Pubitemid 38229537)
52. Walsh R, Boyer C, LaCorte J, et al: N-terminal B-type natriuretic peptide levels in pediatric patients with congestive heart failure undergoing cardiac surgery. J Thorac Cardiovasc Surg 2008; 135:98-105.
53. Tissières P, da Cruz E, Habre W, et al: Value of brain natriuretic peptide in the perioperative follow-up of children with valvular disease. Intensive Care Med 2008; 34: 1109-1113. (Pubitemid 351903791)
54. Gessler P, Knirsch W, Schmitt B, et al: Prognostic value of plasma N-terminal probrain natriuretic peptide in children with congenital heart defects and open-heart surgery. J Pediatr 2006; 148:372-376.
55. Costello JM, Backer CL, Checchia PA, et al: Effect of cardiopulmonary bypass and surgical intervention on the natriuretic hormone system in children. J Thorac Cardiovasc Surg 2005; 130:822-829. (Pubitemid 41265726)
56. Koch A, Kitzsteiner T, Zink S, et al: Impact of cardiac surgery on plasma levels of Btype natriuretic peptide in children with congenital heart disease. Int J Cardiol 2007; 114:339-344. (Pubitemid 44855912)
57. Hsu JH, Keller RL, Chikovani O, et al: Btype natriuretic peptide levels predict outcome after neonatal cardiac surgery. J Thorac Cardiovasc Surg 2007; 134:939-945. (Pubitemid 47445583)
58. Hsu JH, Oishi PE, Keller RL, et al: Perioperative B-type natriuretic peptide levels predict outcome after bidirectional cavopulmonary anastomosis and total cavopulmonary connection. J Thorac Cardiovasc Surg 2008; 135:746-753. (Pubitemid 351417935)
59. Mir TS, Haun C, Lilje C, et al: Utility of N-terminal brain natriuretic peptide plasma concentrations in comparison to lactate and troponin in children with congenital heart disease following open-heart surgery. Pediatr Cardiol 2006; 27:209-216.
60. Shih CY, Sapru A, Oishi P, et al: Alterations in plasma B-type natriuretic peptide levels after repair of congenital heart defects: A potential perioperative marker. J Thorac Cardiovasc Surg 2006; 131:632-638.
61. Breuer T, Sápi E, Skoumal R, et al: N-terminal probrain natriuretic peptide level inversely correlates with cardiac index after arterial switch operation in neonates. Paediatr Anaesth 2007; 17:782-788. (Pubitemid 47000671)
62. Cannesson M, Bionda C, Gostoli B, et al: Time course and prognostic value of plasma B-type natriuretic peptide concentration in neonates undergoing the arterial switch operation. Anesth Analg 2007; 104: 1059-1065, tables of contents. (Pubitemid 46649922)
63. Berry JG, Askovich B, Shaddy RE, et al: Prognostic value of B-type natriuretic peptide in surgical palliation of children with single-ventricle congenital heart disease. Pediatr Cardiol 2008; 29:70-75.
64. Carmona F, Manso PH, Vicente WV, et al: Risk stratification in neonates and infants submitted to cardiac surgery with cardiopulmonary bypass: A multimarker approach combining inflammatory mediators, N-terminal pro-B-type natriuretic peptide and troponin I. Cytokine 2008; 42:317-324.
65. Bronicki RA, Anas NG: Cardiopulmonary interaction. Pediatr Crit Care Med 2009; 10: 313-322.
66. Chien JY, Lin MS, Huang YC, et al: Changes in B-type natriuretic peptide improve weaning outcome predicted by spontaneous breathing trial. Crit Care Med 2008; 36: 1421-1426.
67. Porapakkham P, Porapakkham P, Zimmet H, et al: B-type natriuretic peptide-guided heart failure therapy: A meta-analysis. Arch Intern Med 2010; 170:507-514.
68. Felker GM, Hasselblad V, Hernandez AF, et al: Biomarker-guided therapy in chronic heart failure: A meta-analysis of randomized controlled trials. Am Heart J 2009; 158:422-430.
69. Valle R, Aspromonte N, Giovinazzo P, et al: B-type natriuretic Peptide-guided treatment for predicting outcome in patients hospitalized in sub-intensive care unit with acute heart failure. J Card Fail 2008; 14: 219-224. (Pubitemid 351444865)
70. Adams JE 3rd, Bodor GS, Dávila-Román VG, et al: Cardiac troponin I. A marker with high specificity for cardiac injury. Circulation 1993; 88:101-106. (Pubitemid 23195438)
71. Cummins B, Auckland ML, Cummins P: Cardiac-specific troponin-I radioimmunoassay in the diagnosis of acute myocardial infarction. Am Heart J 1987; 113: 1333-1344. (Pubitemid 17092802)
72. Larue C, Defacque-Lacquement H, Calzolari C, et al: New monoclonal antibodies as probes for human cardiac troponin I: Epitopic analysis with synthetic peptides. Mol Immunol 1992; 29:271-278.
73. Wilkinson JM, Grand RJ: The amino-acid sequence of chicken fast-skeletal-muscle troponin I. Eur J Biochem 1978; 82: 493-501. (Pubitemid 8260504)
74. Heidenreich PA, Alloggiamento T, Melsop K, et al: The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: A meta-analysis. J Am Coll Cardiol 2001; 38:478-485. (Pubitemid 32721777)
75. Wong CK, White HD: Implications of the new definition of myocardial infarction. Postgrad Med J 2005; 81:552-555. (Pubitemid 41297909)
76. Toyo-Oka T, Ross J Jr: Ca2 sensitivity change and troponin loss in cardiac natural actomyosin after coronary occlusion. Am J Physiol 1981; 240:H704-H708. (Pubitemid 11112678)
77. Chiu A, Chan WK, Cheng SH, et al: Troponin- I, myoglobin, and mass concentration of creatine kinase-MB in acute myocardial infarction. QJM 1999; 92:711-718.
78. Ellis AK: Serum protein measurements and the diagnosis of acute myocardial infarction. Circulation 1991; 83:1107-1109.
79. Katus HA, Remppis A, Neumann FJ, et al: Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation 1991; 83:902-912.
80. Mair J, Artner-Dworzak E, Lechleitner P, et al: Cardiac troponin T in diagnosis of acute myocardial infarction. Clin Chem 1991; 37: 845-852. (Pubitemid 21925927)
81. Mair J, Wieser C, Seibt I, et al: Troponin T to diagnose myocardial infarction in bypass surgery. Lancet 1991; 337:434-435.
82. Kavsak PA, Wang X, Ko DT, et al: Short- and long-term risk stratification using a nextgeneration, high-sensitivity research cardiac troponin I (hs-cTnI) assay in an emergency department chest pain population. Clin Chem 2009; 55:1809-1815.
83. Keller T, Zeller T, Peetz D, et al: Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009; 361:868-877.
84. Reichlin T, Hochholzer W, Bassetti S, et al: Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009; 361:858-867.
85. Alpert JS, Thygesen K, Antman E, et al: Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000; 36:959-969.
86. Jaffe AS, Ravkilde J, Roberts R, et al: It's time for a change to a troponin standard. Circulation 2000; 102:1216-1220.
87. Morrow DA, Cannon CP, Jesse RL, et al: National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Circulation 2007; 115:e356-e375. (Pubitemid 46648624)
88. Evaluation of a bedside whole-blood rapid troponin T assay in the emergency department. Rapid Evaluation by Assay of Cardiac Troponin T (REACTT) Investigators Study Group. Acad Emerg Med 1997; 4:1018-1024.
89. Sasse S, Brand NJ, Kyprianou P, et al: Troponin I gene expression during human car- diac development and in end-stage heart failure. Circ Res 1993; 72:932-938. (Pubitemid 23105498)
90. Hirsch R, Landt Y, Porter S, et al: Cardiac troponin I in pediatrics: Normal values and potential use in the assessment of cardiac injury. J Pediatr 1997; 130:872-877. (Pubitemid 27495113)
91. Towbin JA, Gajarski RJ: Cardiac troponin I: A new diagnostic gold standard of cardiac injury in children? J Pediatr 1997; 130: 853-855. (Pubitemid 27495108)
92. Kanaan UB, Chiang VW: Cardiac troponins in pediatrics. Pediatr Emerg Care 2004; 20: 323-329.
93. McAuliffe F, Mears K, Fleming S, et al: Fetal cardiac troponin I in relation to intrapartum events and umbilical artery pH. Am J Perinatol 2004; 21:147-152. (Pubitemid 38506909)
94. Quivers ES, Murthy JN, Soldin SJ: The effect of gestational age, birth weight, and disease on troponin I and creatine kinase MB in the first year of life. Clin Biochem 1999; 32:419-421. (Pubitemid 29536173)
95. Soldin SJ, Murthy JN, Agarwalla PK, et al: Pediatric reference ranges for creatine kinase, CKMB, Troponin I, iron, and cortisol. Clin Biochem 1999; 32:77-80. (Pubitemid 29095770)
96. Trevisanuto D, Pitton M, Altinier S, et al: Cardiac troponin I, cardiac troponin T and creatine kinase MB concentrations in umbilical cord blood of healthy term neonates. Acta Paediatr 2003; 92:1463-1467. (Pubitemid 38114497)
97. Tü rker G, Babaogilu K, Gö kalp AS, et al: Cord blood cardiac troponin I as an early predictor of short-term outcome in perinatal hypoxia. Biol Neonate 2004; 86:131-137.
98. Ammann P, Maggiorini M, Bertel O, et al: Troponin as a risk factor for mortality in critically ill patients without acute coronary syndromes. J Am Coll Cardiol 2003; 41: 2004-2009. (Pubitemid 36677123)
99. Babuin L, Jaffe AS: Troponin: The biomarker of choice for the detection of cardiac injury. CMAJ 2005; 173:1191-1202. (Pubitemid 41637819)
100. Babuin L, Vasile VC, Rio Perez JA, et al: Elevated cardiac troponin is an independent risk factor for short- and long-term mortality in medical intensive care unit patients. Crit Care Med 2008; 36:759-765.
101. Fenton KE, Sable CA, Bell MJ, et al: Increases in serum levels of troponin I are associated with cardiac dysfunction and disease severity in pediatric patients with septic shock. Pediatr Crit Care Med 2004; 5:533-538.
102. John J, Woodward DB, Wang Y, et al: Troponin- I as a prognosticator of mortality in severe sepsis patients. J Crit Care 2010; 25:270-275.
103. Roongsritong C, Warraich I, Bradley C: Common causes of troponin elevations in the absence of acute myocardial infarction: Incidence and clinical significance. Chest 2004; 125:1877-1884. (Pubitemid 38648423)
104. Checchia PA, Moynihan JA, Brown L: Cardiac troponin I as a predictor of mortality for pediatric submersion injuries requiring out-of-hospital cardiopulmonary resuscitation. Pediatr Emerg Care 2006; 22:222-225. (Pubitemid 43772169)
105. Ammann P, Fehr T, Minder EI, et al: Elevation of troponin I in sepsis and septic shock. Intensive Care Med 2001; 27: 965-969. (Pubitemid 32662476)
106. Arlati S, Brenna S, Prencipe L, et al: Myocardial necrosis in ICU patients with acute non-cardiac disease: A prospective study. Intensive Care Med 2000; 26:31-37. (Pubitemid 30184457)
107. Mehta NJ, Khan IA, Gupta V, et al: Cardiac troponin I predicts myocardial dysfunction and adverse outcome in septic shock. Int J Cardiol 2004; 95:13-17. (Pubitemid 38670466)
108. King DA, Codish S, Novack V, et al: The role of cardiac troponin I as a prognosticator in critically ill medical patients: A prospective observational cohort study. Crit Care 2005; 9:R390-R395.
109. Landesberg G, Vesselov Y, Einav S, et al: Myocardial ischemia, cardiac troponin, and long-term survival of high-cardiac risk critically ill intensive care unit patients. Crit Care Med 2005; 33:1281-1287. (Pubitemid 40827379)
110. Lim W, Qushmaq I, Cook DJ, et al: Elevated troponin and myocardial infarction in the intensive care unit: A prospective study. Crit Care 2005; 9:R636-R644.
111. Quenot JP, Le Teuff G, Quantin C, et al: Myocardial injury in critically ill patients: Relation to increased cardiac troponin I and hospital mortality. Chest 2005; 128: 2758-2764. (Pubitemid 41507637)
112. Wu TT, Yuan A, Chen CY, et al: Cardiac troponin I levels are a risk factor for mortality and multiple organ failure in noncardiac critically ill patients and have an additive effect to the APACHE II score in outcome prediction. Shock 2004; 22: 95-101. (Pubitemid 40228185)
113. ver Elst KM, Spapen HD, Nguyen DN, et al: Cardiac troponins I and T are biological markers of left ventricular dysfunction in septic shock. Clin Chem 2000; 46:650-657. (Pubitemid 30318420)
114. Vieillard-Baron A, Caille V, Charron C, et al: Actual incidence of global left ventricular hypokinesia in adult septic shock. Crit Care Med 2008; 36:1701-1706.
115. Guest TM, Ramanathan AV, Tuteur PG, et al: Myocardial injury in critically ill patients. A frequently unrecognized complication. JAMA 1995; 273:1945-1949.
116. Kollef MH, Ladenson JH, Eisenberg PR: Clinically recognized cardiac dysfunction: An independent determinant of mortality among critically ill patients. Is there a role for serial measurement of cardiac troponin I? Chest 1997; 111:1340-1347. (Pubitemid 27200094)
117. Turner A, Tsamitros M, Bellomo R: Myocardial cell injury in septic shock. Crit Care Med 1999; 27:1775-1780. (Pubitemid 29455103)
118. Briassoulis G, Narlioglou M, Zavras N, et al: Myocardial injury in meningococcusinduced purpura fulminans in children. Intensive Care Med 2001; 27:1073-1082. (Pubitemid 32662491)
119. Thiru Y, Pathan N, Bignall S, et al: A myocardial cytotoxic process is involved in the cardiac dysfunction of meningococcal septic shock. Crit Care Med 2000; 28: 2979-2983.
120. Moynihan JA, Brown L, Sehra R, et al: Cardiac troponin I as a predictor of respiratory failure in children hospitalized with respiratory syncytial virus (RSV) infections: A pilot study. Am J Emerg Med 2003; 21: 479-482. (Pubitemid 37322886)
121. Checchia PA, Appel HJ, Kahn S, et al: Myocardial injury in children with respiratory syncytial virus infection. Pediatr Crit Care Med 2000; 1:146-150.
122. deFilippi C, Wasserman S, Rosanio S, et al: Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis. JAMA 2003; 290:353-359. (Pubitemid 37430521)
123. Clark GL, Robison AK, Gnepp DR, et al: Effects of lymphatic transport of enzyme on plasma creatine kinase time-activity curves after myocardial infarction in dogs. Circ Res 1978; 43:162-169. (Pubitemid 9004278)
124. Klocke FJ, Copley DP, Krawczyk JA, et al: Rapid renal clearance of immunoreactive canine plasma myoglobin. Circulation 1982; 65:1522-1528. (Pubitemid 12123651)
125. Mallamaci F, Zoccali C, Parlongo S, et al: Troponin is related to left ventricular mass and predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 2002; 40:68-75. (Pubitemid 34701213)
126. Fredericks S, Chang R, Gregson H, et al: Circulating cardiac troponin-T in patients before and after renal transplantation. Clin Chim Acta 2001; 310:199-203. (Pubitemid 32728350)
127. Ellis K, Dreisbach AW, Lertora JL: Plasma elimination of cardiac troponin I in endstage renal disease. South Med J 2001; 94: 993-996. (Pubitemid 33753063)
128. Davis GK, Labugger R, Van Eyk JE, et al: Cardiac troponin T is not detected in Western blots of diseased renal tissue. Clin Chem 2001; 47:782-783. (Pubitemid 32275836)
129. Khan NA, Hemmelgarn BR, Tonelli M, et al: Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: A meta-analysis. Circulation 2005; 112:3088-3096. (Pubitemid 43113440)
130. Adams JE 3rd, Schechtman KB, Landt Y, et al: Comparable detection of acute myocardial infarction by creatine kinase MB isoenzyme and cardiac troponin I. Clin Chem 1994; 40:1291-1295. (Pubitemid 24205946)
131. Bonnefoy E, Filley S, Kirkorian G, et al: Troponin I, troponin T, or creatine kinase- MB to detect perioperative myocardial damage after coronary artery bypass surgery. Chest 1998; 114:482-486. (Pubitemid 28387527)
132. Pichon H, Chocron S, Alwan K, et al: Crystalloid versus cold blood cardioplegia and cardiac troponin I release. Circulation 1997; 96:316-320. (Pubitemid 27298438)
133. Swaanenburg JC, Loef BG, Volmer M, et al: Creatine kinase MB, troponin I, and troponin T release patterns after coronary artery bypass grafting with or without cardiopulmonary bypass and after aortic and mitral valve surgery. Clin Chem 2001; 47: 584-587. (Pubitemid 32222477)
134. Immer FF, Stocker F, Seiler AM, et al: Troponin- T: Improved diagnostic assessment of myocardial damage in childhood. Acta Paediatr 1997; 86:1321-1327. (Pubitemid 28051510)
135. Taggart DP, Hadjinikolas L, Wong K, et al: Vulnerability of paediatric myocardium to cardiac surgery. Heart 1996; 76:214-217. (Pubitemid 26290518)
136. Fellahi JL, Gué X, Richomme X, et al: Short- and long-term prognostic value of postoperative cardiac troponin I concentration in patients undergoing coronary artery bypass grafting. Anesthesiology 2003; 99: 270-274. (Pubitemid 36909551)
137. Greenson N, Macoviak J, Krishnaswamy P, et al: Usefulness of cardiac troponin I in patients undergoing open heart surgery. Am Heart J 2001; 141:447-455. (Pubitemid 32200275)
138. Koh TW, Hooper J, Kemp M, et al: Intraoperative release of troponin T in coronary venous and arterial blood and its relation to recovery of left ventricular function and oxidative metabolism following coronary artery surgery. Heart 1998; 80:341-348. (Pubitemid 28470764)
139. Nesher N, Alghamdi AA, Singh SK, et al: Troponin after cardiac surgery: A predictor or a phenomenon? Ann Thorac Surg 2008; 85:1348-1354. (Pubitemid 351381695)
140. Paparella D, Cappabianca G, Visicchio G, et al: Cardiac troponin I release after coronary artery bypass grafting operation: Effects on operative and midterm survival. Ann Thorac Surg 2005; 80:1758-1764. (Pubitemid 41464297)
141. Mildh LH, Pettila V, Sairanen HI, et al: Cardiac troponin T levels for risk stratification in pediatric open heart surgery. Ann Thorac Surg 2006; 82:1643-1648. (Pubitemid 44584888)
142. Lipshultz SE, Rifai N, Sallan SE, et al: Predictive value of cardiac troponin T in pediatric patients at risk for myocardial injury. Circulation 1997; 96:2641-2648. (Pubitemid 27451357)
143. Checchia PA, Backer CL, Bronicki RA, et al: Dexamethasone reduces postoperative troponin levels in children undergoing cardiopulmonary bypass. Crit Care Med 2003; 31: 1742-1745. (Pubitemid 36714231)
144. Checchia PA, Bronicki RA, Costello JM, et al: Steroid use before pediatric cardiac operations using cardiopulmonary bypass: An international survey of 36 centers. Pediatr Crit Care Med 2005; 6:441-444. (Pubitemid 40980824)
145. Maddali MM, Valliattu J, Al Delamie T, et al: Arterial switch operation: Troponin T does not predict ventilation requirements. Asian Cardiovasc Thorac Ann 2008; 16:274-277.
146. Malagon I, Hogenbirk K, van Pelt J, et al: Effect of dexamethasone on postoperative cardiac troponin T production in pediatric cardiac surgery. Intensive Care Med 2005; 31:1420-1426. (Pubitemid 41437737)
147. Malagon I, Hogenbirk K, van Pelt J, et al: Effect of three different anaesthetic agents on the postoperative production of cardiac troponin T in paediatric cardiac surgery. Br J Anaesth 2005; 94:805-809. (Pubitemid 40753998)
148. Nagy ZL, Collins M, Sharpe T, et al: Effect of two different bypass techniques on the serum troponin-T levels in newborns and children: Does pH-Stat provide better protection? Circulation 2003; 108:577-582 (Pubitemid 36961173)